Mycobacterium Tuberculosis Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Publish Date : 2021-03-14 | Publisher : 99Strategy | No Of Page : 92 | Report Id : MRB000118779 |

   

Report

MRB

Mycobacterium Tuberculosis Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Publish Date: 2021-03-14 No Of Page: 92 Report Id: MRB000118779 Publisher: 99Strategy Category: Medical Care

Summary

Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.

The global Mycobacterium Tuberculosis market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global Mycobacterium Tuberculosis market segmented into
Point of Care Test
Nuclear Acid Amplification Tests
Tuberculosis Skin Test
Others

Based on the end-use, the global Mycobacterium Tuberculosis market classified into
Hospitals
Specialty Clinics
Diagnostic Laboratories

Based on geography, the global Mycobacterium Tuberculosis market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are
Thermo Fisher Scientific
Danaher
Mediven
Osang Healthcare
Hologic
Roche
Abbott
Novacyt
DAAN Gene

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL MYCOBACTERIUM TUBERCULOSIS INDUSTRY
2.1 Summary about Mycobacterium Tuberculosis Industry
2.2 Mycobacterium Tuberculosis Market Trends
2.2.1 Mycobacterium Tuberculosis Production & Consumption Trends
2.2.2 Mycobacterium Tuberculosis Demand Structure Trends
2.3 Mycobacterium Tuberculosis Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Point of Care Test
4.2.2 Nuclear Acid Amplification Tests
4.2.3 Tuberculosis Skin Test
4.2.4 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospitals
4.3.2 Specialty Clinics
4.3.3 Diagnostic Laboratories
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Point of Care Test
5.2.2 Nuclear Acid Amplification Tests
5.2.3 Tuberculosis Skin Test
5.2.4 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospitals
5.3.2 Specialty Clinics
5.3.3 Diagnostic Laboratories
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Point of Care Test
6.2.2 Nuclear Acid Amplification Tests
6.2.3 Tuberculosis Skin Test
6.2.4 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospitals
6.3.2 Specialty Clinics
6.3.3 Diagnostic Laboratories
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Point of Care Test
7.2.2 Nuclear Acid Amplification Tests
7.2.3 Tuberculosis Skin Test
7.2.4 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospitals
7.3.2 Specialty Clinics
7.3.3 Diagnostic Laboratories
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Point of Care Test
8.2.2 Nuclear Acid Amplification Tests
8.2.3 Tuberculosis Skin Test
8.2.4 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospitals
8.3.2 Specialty Clinics
8.3.3 Diagnostic Laboratories
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Point of Care Test
9.2.2 Nuclear Acid Amplification Tests
9.2.3 Tuberculosis Skin Test
9.2.4 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospitals
9.3.2 Specialty Clinics
9.3.3 Diagnostic Laboratories
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Thermo Fisher Scientific
10.1.2 Danaher
10.1.3 Mediven
10.1.4 Osang Healthcare
10.1.5 Hologic
10.1.6 Roche
10.1.7 Abbott
10.1.8 Novacyt
10.1.9 DAAN Gene
10.2 Mycobacterium Tuberculosis Sales Date of Major Players (2017-2020e)
10.2.1 Thermo Fisher Scientific
10.2.2 Danaher
10.2.3 Mediven
10.2.4 Osang Healthcare
10.2.5 Hologic
10.2.6 Roche
10.2.7 Abbott
10.2.8 Novacyt
10.2.9 DAAN Gene
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Table
1.Table Mycobacterium Tuberculosis Product Type Overview
2.Table Mycobacterium Tuberculosis Product Type Market Share List
3.Table Mycobacterium Tuberculosis Product Type of Major Players
4.Table Brief Introduction of Thermo Fisher Scientific
5.Table Brief Introduction of Danaher
6.Table Brief Introduction of Mediven
7.Table Brief Introduction of Osang Healthcare
8.Table Brief Introduction of Hologic
9.Table Brief Introduction of Roche
10.Table Brief Introduction of Abbott
11.Table Brief Introduction of Novacyt
12.Table Brief Introduction of DAAN Gene
13.Table Products & Services of Thermo Fisher Scientific
14.Table Products & Services of Danaher
15.Table Products & Services of Mediven
16.Table Products & Services of Osang Healthcare
17.Table Products & Services of Hologic
18.Table Products & Services of Roche
19.Table Products & Services of Abbott
20.Table Products & Services of Novacyt
21.Table Products & Services of DAAN Gene
22.Table Market Distribution of Major Players
23.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
24.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
25.Table Global Mycobacterium Tuberculosis Market Forecast (Million USD) by Region 2021f-2026f
26.Table Global Mycobacterium Tuberculosis Market Forecast (Million USD) Share by Region 2021f-2026f
27.Table Global Mycobacterium Tuberculosis Market Forecast (Million USD) by Demand 2021f-2026f
28.Table Global Mycobacterium Tuberculosis Market Forecast (Million USD) Share by Demand 2021f-2026f

Latent Tuberculosis Infection (LTBI) Testing Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Summary Further key aspects of the report indicate that: Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology Chapter 2: Global Industry Summary Chapter 3: Market Dynamics Chapter 4: Global Market Segme ...
Published Date :  2021-03-14

Tuberculosis (TB) Treatment Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Summary Further key aspects of the report indicate that: Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology Chapter 2: Global Industry Summary Chapter 3: Market Dynamics Chapter 4: Global Market Segme ...
Published Date :  2021-03-14

2015-2025 Global Latent Tuberculosis Infection (LTBI) Testing Market Research by Type, End-Use and Region (COVID-19 Version)

Summary The global Latent Tuberculosis Infection (LTBI) Testing market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025. Further key aspects of the report indicate that: Chapter 1: Mark ...
Published Date :  2020-10-20

2015-2025 Global Tuberculosis (TB) Treatment Market Research by Type, End-Use and Region

Summary The global Tuberculosis (TB) Treatment market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025. Further key aspects of the report indicate that: Chapter 1: Market Definition and ...
Published Date :  2020-10-20

2015-2025 Global Mycobacterium Tuberculosis Market Research by Type, End-Use and Region (COVID-19 Version)

Summary The global Mycobacterium Tuberculosis market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025. Further key aspects of the report indicate that: Chapter 1: Market Definition and ...
Published Date :  2020-10-20